Click for best price
Passive Transdermal Drug Delivery Market Size, Share 2022
This report contains market size and forecasts of Passive Transdermal Drug Delivery in global, including the following market information:
Global Passive Transdermal Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Passive Transdermal Drug Delivery Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Passive Transdermal Drug Delivery companies in 2021 (%)
The global Passive Transdermal Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Microfluidics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Passive Transdermal Drug Delivery include 3M, Actavis, Inc., Bayer AG, Boehringer Ingelheim GmbH, Corium International, Inc., Echo Therapeutics, Inc., GlaxoSmithKline plc, Johnson & Johnson (Janssen Pharmaceuticals Inc.) and Mylan N.V., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Passive Transdermal Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Passive Transdermal Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Microfluidics
Smart Pill Technology (SPT)
Global Passive Transdermal Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, by Application, 2021 (%)
Clinic
Hospital
Others
Global Passive Transdermal Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Passive Transdermal Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Passive Transdermal Drug Delivery revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Passive Transdermal Drug Delivery revenues share in global market, 2021 (%)
Key companies Passive Transdermal Drug Delivery sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Passive Transdermal Drug Delivery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
| Report Attributes |
Report Details |
| Report Title |
Passive Transdermal Drug Delivery Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
77 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Passive Transdermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Passive Transdermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Passive Transdermal Drug Delivery Overall Market Size
2.1 Global Passive Transdermal Drug Delivery Market Size: 2021 VS 2028
2.2 Global Passive Transdermal Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Passive Transdermal Drug Delivery Sales: 2017-2028
3 Company Landscape
3.1 Top Passive Transdermal Drug Delivery Players in Global Market
3.2 Top Global Passive Transdermal Drug Delivery Companies Ranked by Revenue
3.3 Global Passive Transdermal Drug Delivery Revenue by Companies
3.4 Global Passive Transdermal Drug Delivery Sales by Companies
3.5 Global Passive Transdermal Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Passive Transdermal Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Passive Transdermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Passive Transdermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Passive Transdermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Passive Transdermal Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Microfluidics
4.1.3 Smart Pill Technology (SPT)
4.2 By Type - Global Passive Transdermal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global Passive Transdermal Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Passive Transdermal Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global Passive Transdermal Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Passive Transdermal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global Passive Transdermal Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Passive Transdermal Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global Passive Transdermal Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Passive Transdermal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global Passive Transdermal Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Passive Transdermal Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global Passive Transdermal Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Passive Transdermal Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America Passive Transdermal Drug Delivery Sales, 2017-2028
6.4.3 US Passive Transdermal Drug Delivery Market Size, 2017-2028
6.4.4 Canada Passive Transdermal Drug Delivery Market Size, 2017-2028
6.4.5 Mexico Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Passive Transdermal Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe Passive Transdermal Drug Delivery Sales, 2017-2028
6.5.3 Germany Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.4 France Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.5 U.K. Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.6 Italy Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.7 Russia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.9 Benelux Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Passive Transdermal Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia Passive Transdermal Drug Delivery Sales, 2017-2028
6.6.3 China Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.4 Japan Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.5 South Korea Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.7 India Passive Transdermal Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Passive Transdermal Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America Passive Transdermal Drug Delivery Sales, 2017-2028
6.7.3 Brazil Passive Transdermal Drug Delivery Market Size, 2017-2028
6.7.4 Argentina Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, 2017-2028
6.8.3 Turkey Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.4 Israel Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.6 UAE Passive Transdermal Drug Delivery Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Major Product Offerings
7.1.4 3M Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Corporate Summary
7.2.2 Actavis, Inc. Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Actavis, Inc. Key News
7.3 Bayer AG
7.3.1 Bayer AG Corporate Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Major Product Offerings
7.3.4 Bayer AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Bayer AG Key News
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporate Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim GmbH Key News
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Corporate Summary
7.5.2 Corium International, Inc. Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Corium International, Inc. Key News
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Corporate Summary
7.6.2 Echo Therapeutics, Inc. Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Echo Therapeutics, Inc. Key News
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Corporate Summary
7.7.2 GlaxoSmithKline plc Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Major Product Offerings
7.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline plc Key News
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Major Product Offerings
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News
7.9 Mylan N.V.
7.9.1 Mylan N.V. Corporate Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Major Product Offerings
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 Mylan N.V. Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Major Product Offerings
7.10.4 Novartis AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Novartis AG Key News
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Noven Pharmaceuticals, Inc. Key News
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Corporate Summary
7.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Major Product Offerings
7.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.12.5 Transdermal Corp. Key News
8 Global Passive Transdermal Drug Delivery Production Capacity, Analysis
8.1 Global Passive Transdermal Drug Delivery Production Capacity, 2017-2028
8.2 Passive Transdermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Passive Transdermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Passive Transdermal Drug Delivery Supply Chain Analysis
10.1 Passive Transdermal Drug Delivery Industry Value Chain
10.2 Passive Transdermal Drug Delivery Upstream Market
10.3 Passive Transdermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Passive Transdermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Passive Transdermal Drug Delivery in Global Market
Table 2. Top Passive Transdermal Drug Delivery Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Passive Transdermal Drug Delivery Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Passive Transdermal Drug Delivery Revenue Share by Companies, 2017-2022
Table 5. Global Passive Transdermal Drug Delivery Sales by Companies, (K Units), 2017-2022
Table 6. Global Passive Transdermal Drug Delivery Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Passive Transdermal Drug Delivery Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Passive Transdermal Drug Delivery Product Type
Table 9. List of Global Tier 1 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2017-2022
Table 15. By Type - Global Passive Transdermal Drug Delivery Sales (K Units), 2023-2028
Table 16. By Application ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2017-2022
Table 20. By Application - Global Passive Transdermal Drug Delivery Sales (K Units), 2023-2028
Table 21. By Region ? Global Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Passive Transdermal Drug Delivery Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2017-2022
Table 25. By Region - Global Passive Transdermal Drug Delivery Sales (K Units), 2023-2028
Table 26. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2017-2022
Table 29. By Country - North America Passive Transdermal Drug Delivery Sales, (K Units), 2023-2028
Table 30. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2017-2022
Table 33. By Country - Europe Passive Transdermal Drug Delivery Sales, (K Units), 2023-2028
Table 34. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2017-2022
Table 37. By Region - Asia Passive Transdermal Drug Delivery Sales, (K Units), 2023-2028
Table 38. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2017-2022
Table 41. By Country - South America Passive Transdermal Drug Delivery Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, (K Units), 2023-2028
Table 46. 3M Corporate Summary
Table 47. 3M Passive Transdermal Drug Delivery Product Offerings
Table 48. 3M Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Actavis, Inc. Corporate Summary
Table 50. Actavis, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 51. Actavis, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Bayer AG Corporate Summary
Table 53. Bayer AG Passive Transdermal Drug Delivery Product Offerings
Table 54. Bayer AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Boehringer Ingelheim GmbH Corporate Summary
Table 56. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Product Offerings
Table 57. Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Corium International, Inc. Corporate Summary
Table 59. Corium International, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 60. Corium International, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Echo Therapeutics, Inc. Corporate Summary
Table 62. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 63. Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. GlaxoSmithKline plc Corporate Summary
Table 65. GlaxoSmithKline plc Passive Transdermal Drug Delivery Product Offerings
Table 66. GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
Table 68. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Product Offerings
Table 69. Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Mylan N.V. Corporate Summary
Table 71. Mylan N.V. Passive Transdermal Drug Delivery Product Offerings
Table 72. Mylan N.V. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Novartis AG Corporate Summary
Table 74. Novartis AG Passive Transdermal Drug Delivery Product Offerings
Table 75. Novartis AG Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Noven Pharmaceuticals, Inc. Corporate Summary
Table 77. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Product Offerings
Table 78. Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. Transdermal Corp. Corporate Summary
Table 80. Transdermal Corp. Passive Transdermal Drug Delivery Product Offerings
Table 81. Transdermal Corp. Passive Transdermal Drug Delivery Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. Passive Transdermal Drug Delivery Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 83. Global Passive Transdermal Drug Delivery Capacity Market Share of Key Manufacturers, 2020-2022
Table 84. Global Passive Transdermal Drug Delivery Production by Region, 2017-2022 (K Units)
Table 85. Global Passive Transdermal Drug Delivery Production by Region, 2023-2028 (K Units)
Table 86. Passive Transdermal Drug Delivery Market Opportunities & Trends in Global Market
Table 87. Passive Transdermal Drug Delivery Market Drivers in Global Market
Table 88. Passive Transdermal Drug Delivery Market Restraints in Global Market
Table 89. Passive Transdermal Drug Delivery Raw Materials
Table 90. Passive Transdermal Drug Delivery Raw Materials Suppliers in Global Market
Table 91. Typical Passive Transdermal Drug Delivery Downstream
Table 92. Passive Transdermal Drug Delivery Downstream Clients in Global Market
Table 93. Passive Transdermal Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Passive Transdermal Drug Delivery Segment by Type
Figure 2. Passive Transdermal Drug Delivery Segment by Application
Figure 3. Global Passive Transdermal Drug Delivery Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Passive Transdermal Drug Delivery Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Passive Transdermal Drug Delivery Revenue, 2017-2028 (US$, Mn)
Figure 7. Passive Transdermal Drug Delivery Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Passive Transdermal Drug Delivery Revenue in 2021
Figure 9. By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 10. By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 11. By Type - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 13. By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 14. By Application - Global Passive Transdermal Drug Delivery Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 16. By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 17. By Country - North America Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 18. By Country - North America Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 19. US Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 24. Germany Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 25. France Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 33. China Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 37. India Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 39. By Country - South America Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 40. Brazil Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
Figure 44. Turkey Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Passive Transdermal Drug Delivery Revenue, (US$, Mn), 2017-2028
Figure 48. Global Passive Transdermal Drug Delivery Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Passive Transdermal Drug Delivery by Region, 2021 VS 2028
Figure 50. Passive Transdermal Drug Delivery Industry Value Chain
Figure 51. Marketing Channels
